Boston Scientific Sees Return To Double-Digit Growth In Second Half Of 2000
This article was originally published in The Gray Sheet
Executive Summary
Resumption of Boston Scientific's historic 20%-plus annual sales growth rate will occur the second half of 2000, the company is assuring investors, as key holes in the firm's product pipeline are filled early in the year, including release of advanced coronary stent systems.